Coherent Raman Imaging
Label-free chemometric imaging for objective,
AI-assisted cell analysis and tissue diagnosis
CRI brings together ultra-fast fibre based lasers and Coherent Raman scattering microscopy to make high-speed truly label free imaging possible, scanning tumour tissue in seconds.
Investors
The company is
in partnership with
Is your company interested
in CRI technology?
The company has received grant funding from
The company is a spinout of
News
Latest on chemometric imaging
Cambridge Raman Imaging in the Spotlight: Insights from Our Interim CEO
We are pleased to share that Francesco Crisafi, Interim CEO and CTO of Cambridge Raman Imaging, was recently interviewed in Novus Light by Antonio...
CRI shines at ICORS 2024 in Rome
Matteo Negro and Giulio Cerullo delve into the transformative potential of coherent Raman scattering microscopy in pharmaceutical production and drug discovery.
CRI’s CEO and co-founder discuss the potential of Raman microscopy in pharmaceutical industry
Matteo Negro and Giulio Cerullo delve into the transformative potential of coherent Raman scattering microscopy in pharmaceutical production and drug discovery.